PerspectiveMicrobiology

Indispensable malaria genes

See allHide authors and affiliations

Science  04 May 2018:
Vol. 360, Issue 6388, pp. 490-491
DOI: 10.1126/science.aat5092

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Summary

Malaria parasites, carried by mosquitoes and transmitted to humans, infect ∼200 million individuals and cause ∼500,000 deaths each year (1). Fifteen years after identifying the genome sequence of a malaria-causing parasite, Plasmodium falciparum, malaria treatments still rely heavily on chemicals derived from natural products that were used centuries ago (2). With cell-based functional assays, the gap between genome sequences of Plasmodium spp. and the identification of valuable new therapeutics may be reduced by determining which genes are essential for parasite propagation in the disease-causing blood stage of the parasite life-cycle. The most potent and clinically useful antimalarial drugs rapidly eliminate parasites growing in red blood cells (RBCs). On page 506 of this issue, Zhang et al. (3) report a mutagenesis screen on P. falciparum cultured in human RBCs, identifying 2680 indispensable parasite genes, which may contain antimalarial drug targets. However, it is important to critically assess what fraction of these essential genes will be good drug targets and how one should prioritize such targets for drug discovery.